Dermatology – pustular psoriasis


Randomized, double-blind, placebo-controlled phase 3 study to evaluate the efficacy and safety of an investigational medicinal device in the treatment of adult patients with generalized pustular psoriasis.

More information:

Patients 18-80 years of age with a confirmed clinical diagnosis of generalized pustular psoriasis or experiencing a first episode of the disease without concomitant form of psoriasis can participate in the study.

For your participation in the study, you receive:

  • qualifying visit,
  • control visits to assess the effectiveness of treatment,
  • a wide panel of diagnostic and control tests,
  • medical care related to the study,
  • 4 weeks of treatment, with a possible extension to 8 months,
  • an outstanding dermatologist as an attending physician.

Start of study recruitment: December 2021

Do you have questions about the study?

Call the Clinical Study Coordinator +48 734 129 810